APA (7th ed.) Citation

Hsu, Y., Tseng, C., & Kao, J. (2023). Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm. Clinical and Molecular Hepatology, 29(4), 869-890. https://doi.org/10.3350/cmh.2022.0420

Chicago Style (17th ed.) Citation

Hsu, Yao-Chun, Cheng-Hao Tseng, and Jia-Horng Kao. "Safety Considerations for Withdrawal of Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B: First, Do No Harm." Clinical and Molecular Hepatology 29, no. 4 (2023): 869-890. https://doi.org/10.3350/cmh.2022.0420.

MLA (8th ed.) Citation

Hsu, Yao-Chun, et al. "Safety Considerations for Withdrawal of Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B: First, Do No Harm." Clinical and Molecular Hepatology, vol. 29, no. 4, 2023, pp. 869-890, https://doi.org/10.3350/cmh.2022.0420.

Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.